Skip to main content
The Egyptian Heart Journal

Table 3 Unreasonable medication omission over 12 months

From: Implementation of clinical audit to improve adherence to guideline-recommended therapy in acute coronary syndrome

Drugs

Unjustifiable reason for omission of drugs

N

DAPT

Medication omission error by prescriber

2

ACEI

Borderline blood pressure level

15

Borderline potassium level

7

Medication omission error by prescriber

11

Transcribing error in discharge prescription

8

Borderline serum creatinine level

6

Contrast-induced nephropathy during hospital admission

13

Beta-blockers

Medication omission error by prescriber

19

Non-revascularized RCA

14

Fear of worsening lung function in patients with COPD

7

Apprehensive to initiate beta-blocker and plan to introduce at follow-up

22

  1. DAPT dual antiplatelet therapy, ACEI angiotensin-converting enzyme inhibitor, RCA right coronary artery, COPD chronic obstructive pulmonary disease
Back to article page